<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01941485</url>
  </required_header>
  <id_info>
    <org_study_id>A01354</org_study_id>
    <nct_id>NCT01941485</nct_id>
  </id_info>
  <brief_title>WaveLight® Refractive Flap Accuracy Study</brief_title>
  <official_title>A Prospective, Global, Multi-Center Study to Evaluate Longitudinal Flap Accuracy on Subjects Undergoing Myopic Refractive Surgery Using the WaveLight® Refractive Suite</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the accuracy of the WaveLight FS200 femtosecond
      laser, as assessed by 1 day and 1 month post-operative optical coherence tomography (OCT)
      anterior segment corneal measurements compared to pre-operative flap thickness target.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operatively</measure>
    <time_frame>Day 1 Postoperative</time_frame>
    <description>The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness at Day 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Development of Opaque Bubble Layer (OBL)</measure>
    <time_frame>Operation/Surgery (Day 1)</time_frame>
    <description>OBL (the collection of gas bubbles during corneal flap creation) was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of participants with opaque bubble layer development during femtosecond flap creation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extent of Opaque Bubble Layer (OBL) Within the Femtosecond Flap</measure>
    <time_frame>Operation/Surgery (Day 1)</time_frame>
    <description>The extent of OBL was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of flap with opaque bubble layer development during femtosecond flap creation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined Preoperatively</measure>
    <time_frame>Month 1 Postoperative</time_frame>
    <description>The expected flap thickness as determined pre-operatively subtracted from the achieved flap thickness at Month 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uncorrected Visual Acuity (UCVA)</measure>
    <time_frame>Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>Visual acuity (VA) without spectacles or other visual corrective devices, was performed with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart set at a distance of 4 meters. UCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best Corrected Visual Acuity (BCVA)</measure>
    <time_frame>Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>VA with the subjects's best spectacles or other visual corrective devices, was performed with an ETDRS chart set at a distance of 4 meters. BCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manifest Refraction (Sphere)</measure>
    <time_frame>Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manifest Refraction (Cylinder)</measure>
    <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Contrast Sensitivity (CS)</measure>
    <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity. Both eyes contributed to the analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)</measure>
    <time_frame>Operation/Surgery (Day 1), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>The diameter of the corneal flap was assessed by OCT (ie. an imaging method using light to capture three-dimensional images). Corneal flap is measured in millimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wavefront Aberrometry</measure>
    <time_frame>Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trefoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Response: &quot;Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses&quot;</measure>
    <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Response to &quot;Have Always Worn Glasses or Contact Lenses in the Past 4 Weeks&quot;</measure>
    <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Response by Category: &quot;I Worry About my Vision&quot;</measure>
    <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>As recorded by the subject on the RSVP questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Response by Category: &quot;My Vision is a Concern in my Daily Life&quot;</measure>
    <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>As recorded by the subject on the RSVP questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Response by Category: &quot;Driving at Night&quot;</measure>
    <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>As recorded by the subject on the RSVP questionnaire, where 0 is &quot;Not applicable&quot;, 1 is &quot;No difficulty at all&quot;, 2 is &quot;A little difficulty&quot;, 3 is &quot;Moderate difficulty&quot;, 4 is &quot;Severe difficulty&quot; and 5 is &quot;So much difficulty that I did not do the activity with this alternative&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Curvature as Measured by Keratometry</measure>
    <time_frame>Baseline/Screening (Day 0), 1 Month Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>Corneal curvature as assessed by a commercially available system and measured in diopters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flap Creation Time as Documented in the Log Files</measure>
    <time_frame>Operation/Surgery (Day 1)</time_frame>
    <description>The time to create the flap with FS200 Femtosecond Flap Creation System, measured in seconds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Topography: Q-value</measure>
    <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>The Q-value (a measure of corneal asphericity) was assessed using a commercially available system. The Q-values are negative (−1 &lt; Q &lt; 0) for prolate corneas, in which the central curvature is steeper than the peripheral curvature, and positive (Q &gt; 0) for oblate corneas, in which the central curvature is flatter than the peripheral curvature.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Topography: Anterior Chamber (AC) Volume</measure>
    <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>The AC volume (a measure of the shallowness of the anterior chamber) was assessed using a commercially available system. The lower the chamber volume, the more shallow the anterior chamber or the chamber angle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Topography: Anterior Chamber (AC) Depth</measure>
    <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>The AC depth (axial distance between the anterior surface of the cornea and the anterior surface of the lens) was assessed using a commercially available system. A higher value represents a longer distance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Topography: Angles</measure>
    <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
    <description>The angles (angular measurement of the space between the iris and the lens) were assessed using a commercially available system. The higher the value, the bigger the space.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>WaveLight Refractive Suite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LASIK surgery (laser in situ keratomileusis) per standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WaveLight® Refractive Suite</intervention_name>
    <description>Excimer EX500 and Femtosecond FS200 lasers (Wavelight® Refractive Suite) used during LASIK surgery for corneal flap creation and corneal ablation</description>
    <arm_group_label>WaveLight Refractive Suite</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LASIK surgery</intervention_name>
    <description>Surgical procedure for treating refractive error based on corneal reshaping</description>
    <arm_group_label>WaveLight Refractive Suite</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing and able to understand and sign an informed consent form.

          -  Have refractive error (in both eyes) that requires refractive surgery.

          -  Willing to undergo LASIK surgery using the Wavelight® Refractive Suite.

          -  Myopia between 0.00 to -12.0 Diopters pre-operatively.

          -  Astigmatism between 0.00 to +6.00 Diopters pre-operatively.

          -  Willing and able to attend post-operative examinations per protocol schedule.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Participation in a clinical study within the last 30 days.

          -  History of previous corneal surgery in either eye.

          -  Multifocal ablations in either eye.

          -  PRK or PTK surgery in either eye.

          -  Suffering from acute or recurring eye diseases in either eye, such as corneal ulcers,
             cataract, etc.

          -  Any ocular disease and/or condition that, in the Investigator's clinical judgment, may
             put subject at significant risk, compromise study results, or interfere significantly
             with subject's participation in the study.

          -  Unable to discontinue contact lens wear as specified in protocol.

          -  History of Herpes simplex or Herpes zoster keratitis.

          -  Active ocular rosacea.

          -  Lyme disease.

          -  Severe ocular allergies.

          -  Other medical conditions and use of medications as specified in protocol.

          -  Pregnant or planning to become pregnant during the study.

          -  Other protocol-specified exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sr. Clinical Manager, GCRA, Global Med Affairs, Operations</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2013</study_first_submitted>
  <study_first_submitted_qc>September 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2013</study_first_posted>
  <results_first_submitted>February 1, 2015</results_first_submitted>
  <results_first_submitted_qc>February 1, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 12, 2015</results_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nearsighted</keyword>
  <keyword>astigmatism</keyword>
  <keyword>LASIK</keyword>
  <keyword>refractive surgery</keyword>
  <keyword>WaveLight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were recruited from 1 study center located in the US and 1 study center located in Greece.</recruitment_details>
      <pre_assignment_details>Of the 60 enrolled subjects, 1 was exited as a screen failure prior to surgery. This reporting group includes all enrolled subjects who underwent LASIK surgery (59).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>WaveLight Refractive Suite</title>
          <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This analysis population includes all enrolled subjects who underwent LASIK surgery (59).</population>
      <group_list>
        <group group_id="B1">
          <title>WaveLight Refractive Suite</title>
          <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="59"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.3" spread="9.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operatively</title>
        <description>The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness at Day 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.</description>
        <time_frame>Day 1 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>WaveLight Refractive Suite</title>
            <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
          </group>
        </group_list>
        <measure>
          <title>The Difference Between Achieved Flap Thickness at Day 1 Postoperative as Assessed by OCT and Expected Flap Thickness as Determined Pre-operatively</title>
          <description>The expected flap thickness as determined pre-operatively was subtracted from the achieved flap thickness at Day 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>microns</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.996" spread="12.7509"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.644" spread="10.4762"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Development of Opaque Bubble Layer (OBL)</title>
        <description>OBL (the collection of gas bubbles during corneal flap creation) was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of participants with opaque bubble layer development during femtosecond flap creation.</description>
        <time_frame>Operation/Surgery (Day 1)</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>WaveLight Refractive Suite</title>
            <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Development of Opaque Bubble Layer (OBL)</title>
          <description>OBL (the collection of gas bubbles during corneal flap creation) was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of participants with opaque bubble layer development during femtosecond flap creation.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Extent of Opaque Bubble Layer (OBL) Within the Femtosecond Flap</title>
        <description>The extent of OBL was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of flap with opaque bubble layer development during femtosecond flap creation.</description>
        <time_frame>Operation/Surgery (Day 1)</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>WaveLight Refractive Suite</title>
            <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
          </group>
        </group_list>
        <measure>
          <title>Extent of Opaque Bubble Layer (OBL) Within the Femtosecond Flap</title>
          <description>The extent of OBL was assessed by digital photo analysis of the area covered by the flap and is reported as the percentage of flap with opaque bubble layer development during femtosecond flap creation.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>percentage of flap</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.9" spread="7.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1" spread="6.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined Preoperatively</title>
        <description>The expected flap thickness as determined pre-operatively subtracted from the achieved flap thickness at Month 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.</description>
        <time_frame>Month 1 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
        <group_list>
          <group group_id="O1">
            <title>WaveLight Refractive Suite</title>
            <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
          </group>
        </group_list>
        <measure>
          <title>The Difference Between Achieved Flap Thickness at Month 1 Post-operative as Assessed by OCT and Expected Flap Thickness as Determined Preoperatively</title>
          <description>The expected flap thickness as determined pre-operatively subtracted from the achieved flap thickness at Month 1 postoperative as assessed by optical coherence tomography (ie, an imaging method using light to capture three-dimensional images). Accuracy of flap creation was defined as an achieved thickness within 10 microns of expected thickness.</description>
          <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
          <units>microns</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.638" spread="5.5177"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.207" spread="4.7564"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Uncorrected Visual Acuity (UCVA)</title>
        <description>Visual acuity (VA) without spectacles or other visual corrective devices, was performed with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart set at a distance of 4 meters. UCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.</description>
        <time_frame>Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Day 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 3 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O5">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O6">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Uncorrected Visual Acuity (UCVA)</title>
          <description>Visual acuity (VA) without spectacles or other visual corrective devices, was performed with an Early Treatment Diabetic Retinopathy Study (ETDRS) chart set at a distance of 4 meters. UCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.078" spread="0.4042"/>
                    <measurement group_id="O2" value="0.043" spread="0.1469"/>
                    <measurement group_id="O3" value="-0.021" spread="0.1269"/>
                    <measurement group_id="O4" value="-0.024" spread="0.1123"/>
                    <measurement group_id="O5" value="-0.041" spread="0.0982"/>
                    <measurement group_id="O6" value="-0.059" spread="0.1269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.086" spread="0.3849"/>
                    <measurement group_id="O2" value="0.038" spread="0.1182"/>
                    <measurement group_id="O3" value="-0.029" spread="0.1131"/>
                    <measurement group_id="O4" value="-0.027" spread="0.1129"/>
                    <measurement group_id="O5" value="-0.045" spread="0.1116"/>
                    <measurement group_id="O6" value="-0.067" spread="0.0990"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Both eyes (OU)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.024" spread="0.4289"/>
                    <measurement group_id="O2" value="-0.011" spread="0.1118"/>
                    <measurement group_id="O3" value="-0.070" spread="0.0853"/>
                    <measurement group_id="O4" value="-0.085" spread="0.0786"/>
                    <measurement group_id="O5" value="-0.084" spread="0.0858"/>
                    <measurement group_id="O6" value="-0.134" spread="0.0793"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Best Corrected Visual Acuity (BCVA)</title>
        <description>VA with the subjects's best spectacles or other visual corrective devices, was performed with an ETDRS chart set at a distance of 4 meters. BCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.</description>
        <time_frame>Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Day 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 3 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O5">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O6">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Best Corrected Visual Acuity (BCVA)</title>
          <description>VA with the subjects's best spectacles or other visual corrective devices, was performed with an ETDRS chart set at a distance of 4 meters. BCVA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.00 logMAR corresponding to 20/20 Snellen. A lower logMAR value indicates better visual acuity.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>logMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.046" spread="0.0855"/>
                    <measurement group_id="O2" value="-0.028" spread="0.1097"/>
                    <measurement group_id="O3" value="-0.064" spread="0.0953"/>
                    <measurement group_id="O4" value="-0.072" spread="0.0877"/>
                    <measurement group_id="O5" value="-0.091" spread="0.0810"/>
                    <measurement group_id="O6" value="-0.103" spread="0.0880"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.042" spread="0.0894"/>
                    <measurement group_id="O2" value="-0.027" spread="0.0915"/>
                    <measurement group_id="O3" value="-0.062" spread="0.0947"/>
                    <measurement group_id="O4" value="-0.070" spread="0.0967"/>
                    <measurement group_id="O5" value="-0.086" spread="0.0941"/>
                    <measurement group_id="O6" value="-0.099" spread="0.0976"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Both eyes (OU)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.063" spread="0.0814"/>
                    <measurement group_id="O2" value="-0.051" spread="0.0973"/>
                    <measurement group_id="O3" value="-0.096" spread="0.0907"/>
                    <measurement group_id="O4" value="-0.099" spread="0.0863"/>
                    <measurement group_id="O5" value="-0.111" spread="0.0870"/>
                    <measurement group_id="O6" value="-0.148" spread="0.0837"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Manifest Refraction (Sphere)</title>
        <description>A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.</description>
        <time_frame>Baseline/Screening (Day 0), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>WaveLight Refractive Suite</title>
            <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
          </group>
        </group_list>
        <measure>
          <title>Manifest Refraction (Sphere)</title>
          <description>A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>Diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline/Screening (Day 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.254" spread="2.3340"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.347" spread="0.4174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 1 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.186" spread="0.3304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.153" spread="0.3049"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.167" spread="0.3253"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.165" spread="0.3190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Manifest Refraction (Cylinder)</title>
        <description>A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.</description>
        <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>WaveLight Refractive Suite</title>
            <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
          </group>
        </group_list>
        <measure>
          <title>Manifest Refraction (Cylinder)</title>
          <description>A series of test lenses in graded powers was used to determine which corrective lenses provided the sharpest, clearest vision. Manifest refraction is measured in diopters. Each eye contributed individually to the analysis.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>Diopters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline/Screening (Day 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.95" spread="0.847"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 1 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16" spread="0.242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12 Postoperative</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.17" spread="0.323"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Contrast Sensitivity (CS)</title>
        <description>Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity. Both eyes contributed to the analysis.</description>
        <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 3 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O5">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Contrast Sensitivity (CS)</title>
          <description>Contrast sensitivity (ie, the ability to detect slight changes in luminance before they become indistinguishable) was assessed binocularly with distance manifest correction in place and uncorrected. Contrast sensitivity was assessed at spatial frequencies of 3, 6, 12, and 18 cycles per degree (cpd), where 3.0 cpd = A, 6.0 cpd = B, 12.0 cpd = C, and 18.0 cpd = D. Raw scores were log transformed. A higher numeric value represents better contrast sensitivity. Both eyes contributed to the analysis.</description>
          <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
          <units>logCS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
                <count group_id="O5" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CS A (uncorrected), n=31, 59, 59, 59, 59</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.872" spread="0.5604"/>
                    <measurement group_id="O2" value="1.996" spread="0.1219"/>
                    <measurement group_id="O3" value="1.971" spread="0.1249"/>
                    <measurement group_id="O4" value="2.006" spread="0.1585"/>
                    <measurement group_id="O5" value="2.046" spread="0.1460"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS B (uncorrected), n=30, 59, 59, 59, 59</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.986" spread="0.4934"/>
                    <measurement group_id="O2" value="2.080" spread="0.1427"/>
                    <measurement group_id="O3" value="2.087" spread="0.1571"/>
                    <measurement group_id="O4" value="2.148" spread="0.1428"/>
                    <measurement group_id="O5" value="2.163" spread="0.1588"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS C (uncorrected), n=28, 59, 58, 59, 58</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.687" spread="0.4789"/>
                    <measurement group_id="O2" value="1.802" spread="0.2096"/>
                    <measurement group_id="O3" value="1.802" spread="0.2009"/>
                    <measurement group_id="O4" value="1.833" spread="0.2259"/>
                    <measurement group_id="O5" value="1.866" spread="0.1727"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS D (uncorrected), n=29, 58, 57, 56, 58</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.321" spread="0.5745"/>
                    <measurement group_id="O2" value="1.317" spread="0.2619"/>
                    <measurement group_id="O3" value="1.321" spread="0.2485"/>
                    <measurement group_id="O4" value="1.369" spread="0.2517"/>
                    <measurement group_id="O5" value="1.396" spread="0.2379"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS A (corrected), n=59, 59, 59, 59, 59</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.970" spread="0.1576"/>
                    <measurement group_id="O2" value="1.993" spread="0.1310"/>
                    <measurement group_id="O3" value="2.003" spread="0.0967"/>
                    <measurement group_id="O4" value="2.025" spread="0.1424"/>
                    <measurement group_id="O5" value="2.076" spread="0.1126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS B (corrected), n=59, 59, 59, 59, 59</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.074" spread="0.1779"/>
                    <measurement group_id="O2" value="2.112" spread="0.1502"/>
                    <measurement group_id="O3" value="2.100" spread="0.1424"/>
                    <measurement group_id="O4" value="2.180" spread="0.1243"/>
                    <measurement group_id="O5" value="2.172" spread="0.1545"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS C (corrected), n=59, 59, 58, 59, 58</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.706" spread="0.2716"/>
                    <measurement group_id="O2" value="1.815" spread="0.2017"/>
                    <measurement group_id="O3" value="1.813" spread="0.1970"/>
                    <measurement group_id="O4" value="1.848" spread="0.2211"/>
                    <measurement group_id="O5" value="1.897" spread="0.1538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CS C (corrected), n=57, 58, 57, 56, 58</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.262" spread="0.2657"/>
                    <measurement group_id="O2" value="1.338" spread="0.2713"/>
                    <measurement group_id="O3" value="1.332" spread="0.2491"/>
                    <measurement group_id="O4" value="1.388" spread="0.2501"/>
                    <measurement group_id="O5" value="1.422" spread="0.2292"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)</title>
        <description>The diameter of the corneal flap was assessed by OCT (ie. an imaging method using light to capture three-dimensional images). Corneal flap is measured in millimeters.</description>
        <time_frame>Operation/Surgery (Day 1), Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Operation/Surgery (Day 1)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Day 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 3 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O5">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O6">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Flap Diameter as Assessed by Ocular Coherence Tomography (OCT)</title>
          <description>The diameter of the corneal flap was assessed by OCT (ie. an imaging method using light to capture three-dimensional images). Corneal flap is measured in millimeters.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
                <count group_id="O5" value="59"/>
                <count group_id="O6" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="0.25"/>
                    <measurement group_id="O2" value="8.4" spread="0.25"/>
                    <measurement group_id="O3" value="8.4" spread="0.24"/>
                    <measurement group_id="O4" value="8.4" spread="0.25"/>
                    <measurement group_id="O5" value="8.4" spread="0.25"/>
                    <measurement group_id="O6" value="8.4" spread="0.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="0.27"/>
                    <measurement group_id="O2" value="8.4" spread="0.27"/>
                    <measurement group_id="O3" value="8.4" spread="0.26"/>
                    <measurement group_id="O4" value="8.4" spread="0.27"/>
                    <measurement group_id="O5" value="8.4" spread="0.27"/>
                    <measurement group_id="O6" value="8.4" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wavefront Aberrometry</title>
        <description>Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trefoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology.</description>
        <time_frame>Operation/Surgery (Day 1), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Operation/Surgery (Day 1)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Wavefront Aberrometry</title>
          <description>Wavefront aberrations (optical imperfections of the eye that prevent light from focusing perfectly on the retina, resulting in defects in the visual image) were measured using a commercially available system. Higher order aberrations (i.e., spherical aberrations, coma, and trefoil) are defined as optical imperfections which cannot be corrected by any reliable means of present technology.</description>
          <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
          <units>micrometers</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="57"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Higher Order RMS, Right Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.138"/>
                    <measurement group_id="O2" value="0.64" spread="0.517"/>
                    <measurement group_id="O3" value="0.60" spread="0.445"/>
                    <measurement group_id="O4" value="0.65" spread="0.601"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Higher Order RMS, Left eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="0.246"/>
                    <measurement group_id="O2" value="0.56" spread="0.293"/>
                    <measurement group_id="O3" value="0.57" spread="0.318"/>
                    <measurement group_id="O4" value="0.58" spread="0.375"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spherical Aberration, Right Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0824" spread="0.13093"/>
                    <measurement group_id="O2" value="0.1399" spread="0.23398"/>
                    <measurement group_id="O3" value="0.1646" spread="0.20307"/>
                    <measurement group_id="O4" value="0.1619" spread="0.19886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Spherical Aberration, Left Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0851" spread="0.12651"/>
                    <measurement group_id="O2" value="0.1614" spread="0.20808"/>
                    <measurement group_id="O3" value="0.1727" spread="0.21057"/>
                    <measurement group_id="O4" value="0.1954" spread="0.18350"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Coma, Right Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2059" spread="0.11420"/>
                    <measurement group_id="O2" value="0.3656" spread="0.34574"/>
                    <measurement group_id="O3" value="0.3306" spread="0.34061"/>
                    <measurement group_id="O4" value="0.3416" spread="0.27229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Coma, Left Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2040" spread="0.16540"/>
                    <measurement group_id="O2" value="0.2950" spread="0.16431"/>
                    <measurement group_id="O3" value="0.2927" spread="0.19461"/>
                    <measurement group_id="O4" value="0.2858" spread="0.18065"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trefoil, Right Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1798" spread="0.12264"/>
                    <measurement group_id="O2" value="0.2316" spread="0.24752"/>
                    <measurement group_id="O3" value="0.2440" spread="0.22987"/>
                    <measurement group_id="O4" value="0.2708" spread="0.51291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Trefoil, Left Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2192" spread="0.18534"/>
                    <measurement group_id="O2" value="0.2330" spread="0.21332"/>
                    <measurement group_id="O3" value="0.2400" spread="0.22751"/>
                    <measurement group_id="O4" value="0.2403" spread="0.20733"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Response: &quot;Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses&quot;</title>
        <description>As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision).</description>
        <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Response: &quot;Rate Your Vision, Over the Past 4 Weeks, With NO Glasses or Contact Lenses&quot;</title>
          <description>As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error, on a scale from 0 (completely blind) to 10 (perfect vision).</description>
          <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.7" spread="1.42"/>
                    <measurement group_id="O2" value="9.0" spread="1.03"/>
                    <measurement group_id="O3" value="9.3" spread="0.82"/>
                    <measurement group_id="O4" value="9.2" spread="1.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Response to &quot;Have Always Worn Glasses or Contact Lenses in the Past 4 Weeks&quot;</title>
        <description>As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error.</description>
        <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Response to &quot;Have Always Worn Glasses or Contact Lenses in the Past 4 Weeks&quot;</title>
          <description>As recorded by the subject on the the Refractive Status and Vision Profile (RSVP), a self-reported questionnaire used to measure vision-related health status in persons with refractive error.</description>
          <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.8"/>
                    <measurement group_id="O2" value="100.0"/>
                    <measurement group_id="O3" value="100.0"/>
                    <measurement group_id="O4" value="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.2"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Response by Category: &quot;I Worry About my Vision&quot;</title>
        <description>As recorded by the subject on the RSVP questionnaire</description>
        <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Response by Category: &quot;I Worry About my Vision&quot;</title>
          <description>As recorded by the subject on the RSVP questionnaire</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Never</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.3"/>
                    <measurement group_id="O2" value="27.1"/>
                    <measurement group_id="O3" value="50.8"/>
                    <measurement group_id="O4" value="55.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rarely</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.9"/>
                    <measurement group_id="O2" value="54.2"/>
                    <measurement group_id="O3" value="30.5"/>
                    <measurement group_id="O4" value="23.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sometimes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.2"/>
                    <measurement group_id="O2" value="8.5"/>
                    <measurement group_id="O3" value="11.9"/>
                    <measurement group_id="O4" value="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Often</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.9"/>
                    <measurement group_id="O2" value="8.5"/>
                    <measurement group_id="O3" value="5.1"/>
                    <measurement group_id="O4" value="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Always</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                    <measurement group_id="O2" value="1.7"/>
                    <measurement group_id="O3" value="1.7"/>
                    <measurement group_id="O4" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Response by Category: &quot;My Vision is a Concern in my Daily Life&quot;</title>
        <description>As recorded by the subject on the RSVP questionnaire</description>
        <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Response by Category: &quot;My Vision is a Concern in my Daily Life&quot;</title>
          <description>As recorded by the subject on the RSVP questionnaire</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Never</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4"/>
                    <measurement group_id="O2" value="27.1"/>
                    <measurement group_id="O3" value="44.1"/>
                    <measurement group_id="O4" value="50.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rarely</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.8"/>
                    <measurement group_id="O2" value="49.2"/>
                    <measurement group_id="O3" value="30.5"/>
                    <measurement group_id="O4" value="22.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sometimes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.9"/>
                    <measurement group_id="O2" value="6.8"/>
                    <measurement group_id="O3" value="5.1"/>
                    <measurement group_id="O4" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Often</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5"/>
                    <measurement group_id="O2" value="6.8"/>
                    <measurement group_id="O3" value="3.4"/>
                    <measurement group_id="O4" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Always</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.4"/>
                    <measurement group_id="O2" value="10.2"/>
                    <measurement group_id="O3" value="16.9"/>
                    <measurement group_id="O4" value="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Response by Category: &quot;Driving at Night&quot;</title>
        <description>As recorded by the subject on the RSVP questionnaire, where 0 is &quot;Not applicable&quot;, 1 is &quot;No difficulty at all&quot;, 2 is &quot;A little difficulty&quot;, 3 is &quot;Moderate difficulty&quot;, 4 is &quot;Severe difficulty&quot; and 5 is &quot;So much difficulty that I did not do the activity with this alternative&quot;.</description>
        <time_frame>Baseline/Screening (Day 0), Month 1 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Response by Category: &quot;Driving at Night&quot;</title>
          <description>As recorded by the subject on the RSVP questionnaire, where 0 is &quot;Not applicable&quot;, 1 is &quot;No difficulty at all&quot;, 2 is &quot;A little difficulty&quot;, 3 is &quot;Moderate difficulty&quot;, 4 is &quot;Severe difficulty&quot; and 5 is &quot;So much difficulty that I did not do the activity with this alternative&quot;.</description>
          <population>This analysis population includes all subjects with 1 month post-operative measurements of the primary efficacy endpoint with data at the specific time point.</population>
          <units>percentage of subjects</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>With glasses, 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5"/>
                    <measurement group_id="O2" value="100.0"/>
                    <measurement group_id="O3" value="100.0"/>
                    <measurement group_id="O4" value="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With glasses, 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.1"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With glasses, 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.4"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With glasses, 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With glasses, 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With glasses, 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With contact lenses, 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.1"/>
                    <measurement group_id="O2" value="100.0"/>
                    <measurement group_id="O3" value="100.0"/>
                    <measurement group_id="O4" value="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With contact lenses, 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.1"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With contact lenses, 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With contact lenses, 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With contact lenses, 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>With contact lenses, 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without glasses/contact lenses, 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3"/>
                    <measurement group_id="O2" value="6.8"/>
                    <measurement group_id="O3" value="5.1"/>
                    <measurement group_id="O4" value="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without glasses/contact lenses, 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="66.1"/>
                    <measurement group_id="O3" value="76.3"/>
                    <measurement group_id="O4" value="79.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without glasses/contact lenses, 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="18.6"/>
                    <measurement group_id="O3" value="13.6"/>
                    <measurement group_id="O4" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without glasses/contact lenses, 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8"/>
                    <measurement group_id="O2" value="6.8"/>
                    <measurement group_id="O3" value="5.1"/>
                    <measurement group_id="O4" value="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without glasses/contact lenses, 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.5"/>
                    <measurement group_id="O2" value="1.7"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without glasses/contact lenses, 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.4"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Curvature as Measured by Keratometry</title>
        <description>Corneal curvature as assessed by a commercially available system and measured in diopters.</description>
        <time_frame>Baseline/Screening (Day 0), 1 Month Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>Baseline/Screening (Day 0)</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O2">
            <title>Month 1 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O3">
            <title>Month 3 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O4">
            <title>Month 6 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
          <group group_id="O5">
            <title>Month 12 Postoperative</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Curvature as Measured by Keratometry</title>
          <description>Corneal curvature as assessed by a commercially available system and measured in diopters.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>diopter</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="59"/>
                <count group_id="O4" value="59"/>
                <count group_id="O5" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>K1, Right Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.4" spread="1.58"/>
                    <measurement group_id="O2" value="39.9" spread="2.42"/>
                    <measurement group_id="O3" value="39.9" spread="2.43"/>
                    <measurement group_id="O4" value="40.0" spread="2.36"/>
                    <measurement group_id="O5" value="40.1" spread="2.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>K1, Left Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.5" spread="1.74"/>
                    <measurement group_id="O2" value="39.8" spread="2.37"/>
                    <measurement group_id="O3" value="39.8" spread="2.20"/>
                    <measurement group_id="O4" value="39.9" spread="2.31"/>
                    <measurement group_id="O5" value="40.0" spread="2.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>K2, Right Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.6" spread="1.69"/>
                    <measurement group_id="O2" value="40.6" spread="2.59"/>
                    <measurement group_id="O3" value="40.7" spread="2.52"/>
                    <measurement group_id="O4" value="40.8" spread="2.51"/>
                    <measurement group_id="O5" value="40.8" spread="2.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>K2, Left Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.7" spread="1.78"/>
                    <measurement group_id="O2" value="40.5" spread="2.49"/>
                    <measurement group_id="O3" value="40.5" spread="2.32"/>
                    <measurement group_id="O4" value="40.8" spread="2.37"/>
                    <measurement group_id="O5" value="40.8" spread="2.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean K1 and K2, Right Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.0" spread="1.60"/>
                    <measurement group_id="O2" value="40.3" spread="2.47"/>
                    <measurement group_id="O3" value="40.3" spread="2.46"/>
                    <measurement group_id="O4" value="40.4" spread="2.42"/>
                    <measurement group_id="O5" value="40.5" spread="2.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mean K1 and K2, Left Eye</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.1" spread="1.72"/>
                    <measurement group_id="O2" value="40.1" spread="2.42"/>
                    <measurement group_id="O3" value="40.2" spread="2.25"/>
                    <measurement group_id="O4" value="40.4" spread="2.33"/>
                    <measurement group_id="O5" value="40.4" spread="2.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Flap Creation Time as Documented in the Log Files</title>
        <description>The time to create the flap with FS200 Femtosecond Flap Creation System, measured in seconds.</description>
        <time_frame>Operation/Surgery (Day 1)</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
        <group_list>
          <group group_id="O1">
            <title>FS200 Laser</title>
            <description>Femtosecond FS200 laser used during LASIK surgery for corneal flap creation</description>
          </group>
        </group_list>
        <measure>
          <title>Flap Creation Time as Documented in the Log Files</title>
          <description>The time to create the flap with FS200 Femtosecond Flap Creation System, measured in seconds.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the primary effectiveness endpoint.</population>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right eye (OD)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.864" spread="7.3001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left eye (OS)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.220" spread="7.7550"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Topography: Q-value</title>
        <description>The Q-value (a measure of corneal asphericity) was assessed using a commercially available system. The Q-values are negative (−1 &lt; Q &lt; 0) for prolate corneas, in which the central curvature is steeper than the peripheral curvature, and positive (Q &gt; 0) for oblate corneas, in which the central curvature is flatter than the peripheral curvature.</description>
        <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
        <group_list>
          <group group_id="O1">
            <title>Q-Value</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Topography: Q-value</title>
          <description>The Q-value (a measure of corneal asphericity) was assessed using a commercially available system. The Q-values are negative (−1 &lt; Q &lt; 0) for prolate corneas, in which the central curvature is steeper than the peripheral curvature, and positive (Q &gt; 0) for oblate corneas, in which the central curvature is flatter than the peripheral curvature.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
          <units>unit less</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1 Postoperative, n=116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.30" spread="0.661"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 1 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.31" spread="0.652"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.06" spread="0.769"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.752"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.748"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Topography: Anterior Chamber (AC) Volume</title>
        <description>The AC volume (a measure of the shallowness of the anterior chamber) was assessed using a commercially available system. The lower the chamber volume, the more shallow the anterior chamber or the chamber angle.</description>
        <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
        <group_list>
          <group group_id="O1">
            <title>AC Volume</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Topography: Anterior Chamber (AC) Volume</title>
          <description>The AC volume (a measure of the shallowness of the anterior chamber) was assessed using a commercially available system. The lower the chamber volume, the more shallow the anterior chamber or the chamber angle.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
          <units>millimeters cubed</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1 Postoperative, n=116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="189.98" spread="30.439"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 1 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="195.25" spread="32.134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="192.91" spread="31.156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="191.92" spread="32.985"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="192.64" spread="33.382"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Topography: Anterior Chamber (AC) Depth</title>
        <description>The AC depth (axial distance between the anterior surface of the cornea and the anterior surface of the lens) was assessed using a commercially available system. A higher value represents a longer distance.</description>
        <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
        <group_list>
          <group group_id="O1">
            <title>AC Depth</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Topography: Anterior Chamber (AC) Depth</title>
          <description>The AC depth (axial distance between the anterior surface of the cornea and the anterior surface of the lens) was assessed using a commercially available system. A higher value represents a longer distance.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1 Postoperative, n=116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.43" spread="0.370"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 1 Postoperative, n=117</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.43" spread="0.349"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.38" spread="0.352"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.18" spread="0.272"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.16" spread="0.276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Corneal Topography: Angles</title>
        <description>The angles (angular measurement of the space between the iris and the lens) were assessed using a commercially available system. The higher the value, the bigger the space.</description>
        <time_frame>Day 1 Postoperative, Month 1 Postoperative, Month 3 Postoperative, Month 6 Postoperative, Month 12 Postoperative</time_frame>
        <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
        <group_list>
          <group group_id="O1">
            <title>Angles</title>
            <description>WaveLight Refractive Suite</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Topography: Angles</title>
          <description>The angles (angular measurement of the space between the iris and the lens) were assessed using a commercially available system. The higher the value, the bigger the space.</description>
          <population>This analysis population includes all subjects with 1 day post-operation measurements of the corneal topography endpoint. Here, &quot;n&quot; includes all eyes with data.</population>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1 Postoperative, n=116</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.07" spread="6.612"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 1 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.63" spread="6.155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.09" spread="6.155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.81" spread="6.141"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12 Postoperative, n=118</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.74" spread="6.133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected for the duration of a subject’s participation in the study (up to 12 months). This reporting group includes all enrolled subjects who underwent LASIK surgery.</time_frame>
      <desc>An AE was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in subjects, users or other persons, whether or not related to the medical device.</desc>
      <group_list>
        <group group_id="E1">
          <title>WaveLight Refractive Suite</title>
          <description>Excimer EX500 and Femtosecond FS200 lasers used during LASIK surgery for corneal flap creation and corneal ablation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Global Brand Med Affairs Lead, Refractive, VGR</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

